Glasgow-Blatchford score

From WikiMD's Wellnesspedia

Glasgow-Blatchford score is a risk scoring tool used to predict the need for treatment in patients with upper gastrointestinal bleeding (UGIB). It was developed by Blatchford et al. in 2000 and is named after the city of Glasgow, where the study was conducted.

Overview[edit | edit source]

The Glasgow-Blatchford score is calculated based on several clinical and laboratory parameters, including blood urea nitrogen, hemoglobin, systolic blood pressure, pulse, presentation with melena, presentation with syncope, hepatic disease, and cardiac failure. The score ranges from 0 to 23, with higher scores indicating a higher risk of needing intervention.

Clinical Use[edit | edit source]

The Glasgow-Blatchford score is primarily used to identify patients with UGIB who are at low risk of needing intervention and can be safely managed as outpatients. It has been shown to have a high sensitivity for predicting the need for intervention, but its specificity is lower.

Scoring System[edit | edit source]

The scoring system is as follows:

  • Blood urea nitrogen: 0-2 points
  • Hemoglobin: 0-6 points
  • Systolic blood pressure: 0-3 points
  • Pulse: 0-2 points
  • Presentation with melena: 1 point
  • Presentation with syncope: 2 points
  • Hepatic disease: 2 points
  • Cardiac failure: 2 points

Limitations[edit | edit source]

While the Glasgow-Blatchford score is a useful tool for risk stratification in UGIB, it has some limitations. It does not take into account the patient's age or comorbidities, which can significantly affect the risk of needing intervention. Additionally, it requires laboratory testing, which may not be immediately available in all settings.

See Also[edit | edit source]


Glasgow-Blatchford score Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD